Highbridge Capital Management’s Medicines Co MDCO Stock Holding History

Highbridge Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,649	Closed	-$333K	–	1931
2015 Q2	$333K	Sell	11,649 -111,561	-91%	-$3.11M	﹤0.01%	1111
2015 Q1	$3.45M	Buy	+123,210	New	+$3.46M	0.05%	400
2014 Q4	–	Sell	-18,775	Closed	-$420K	–	1539
2014 Q3	$420K	Buy	18,775 +5,888	+46%	+$150K	0.01%	897
2014 Q2	$374K	Buy	+12,887	New	+$344K	﹤0.01%	812

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Highbridge Capital Management's MDCO Position: Q3 2015 in Review

Highbridge Capital Management sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 11,649 shares — an estimated $333K sold.

Highbridge Capital Management first reported a position in MDCO in Q2 2014 and held it in 4 quarters. The position peaked at $3.45M in Q1 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

Highbridge Capital Management reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
Highbridge Capital Management sold 11,649 Medicines Co shares in Q3 2015, an estimated $333K.
Highbridge Capital Management first reported a position in Medicines Co in Q2 2014 and held it in 4 quarters.
Highbridge Capital Management's Medicines Co position peaked at $3.45M in Q1 2015.
183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Highbridge Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.